We are live on ! Find out more
CWM

Cabot Wealth Management Portfolio holdings

AUM $982M
1-Year Est. Return 21.85%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+21.85%
3 Year Est. Return
+69.26%
5 Year Est. Return
+82.26%
10 Year Est. Return
+369.65%
AUM
$369M
AUM Growth
-$19.5M
Cap. Flow
-$17.7M
Cap. Flow %
-4.79%
Top 10 Hldgs %
25.86%
Holding
160
New
11
Increased
46
Reduced
78
Closed
15

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$5.18M
2
CVS icon
CVS Health
CVS
+$5.05M
3
ILMN icon
Illumina
ILMN
+$3.81M
4
IQV icon
IQVIA
IQV
+$3.77M
5
GOLD
Randgold Resources Ltd
GOLD
+$3.35M

Sector Composition

Rank Sector Weight
1 Financials 12.52%
2 Consumer Discretionary 9.65%
3 Technology 9.2%
4 Communication Services 7.45%
5 Industrials 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
76
Northrop Grumman
NOC
$77.1B
$1.43M 0.39%
6,167
-1,037
-14% -$241K
DXCM icon
77
DexCom
DXCM
$31.5B
$1.39M 0.38%
92,952
-12,196
-12% -$216K
VTIP icon
78
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$1.33M 0.36%
26,986
+3,731
+16% +$184K
GOOGL icon
79
Alphabet (Google) Class A
GOOGL
$4.36T
$1.27M 0.35%
32,180
-2,560
-7% -$102K
PGX icon
80
Invesco Preferred ETF
PGX
$3.81B
$1.27M 0.34%
89,016
-4,193
-4% -$61.1K
PANW icon
81
Palo Alto Networks
PANW
$270B
$1.22M 0.33%
58,746
-12,420
-17% -$298K
BABA icon
82
Alibaba
BABA
$293B
$1.2M 0.33%
+13,699
New +$1.32M
SCHG icon
83
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$1.14M 0.31%
163,584
-8,408
-5% -$58.1K
EEM icon
84
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$1.08M 0.29%
30,840
-5,102
-14% -$184K
BMRN icon
85
BioMarin Pharmaceuticals
BMRN
$11.6B
$978K 0.26%
11,808
-2,553
-18% -$220K
QQQ icon
86
Invesco QQQ Trust
QQQ
$453B
$945K 0.26%
7,979
-407
-5% -$48K
IEMG icon
87
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$905K 0.24%
21,314
+16
+0.1% +$702
FNDC icon
88
Schwab Fundamental International Small Company Index ETF
FNDC
$3.05B
$876K 0.24%
30,864
+8,192
+36% +$235K
FRN
89
DELISTED
Invesco Frontier Markets ETF
FRN
$874K 0.24%
75,571
+14,890
+25% +$175K
SCHC icon
90
Schwab International Small-Cap Equity ETF
SCHC
$5.39B
$851K 0.23%
29,245
+8,101
+38% +$239K
FNDA icon
91
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
$838K 0.23%
49,126
+8,936
+22% +$144K
SCHA icon
92
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$825K 0.22%
53,676
+9,884
+23% +$145K
SIVR icon
93
abrdn Physical Silver Shares ETF
SIVR
$4.02B
$821K 0.22%
52,639
-3,296
-6% -$55.2K
PG icon
94
Procter & Gamble
PG
$336B
$806K 0.22%
9,589
+308
+3% +$26.3K
IJT icon
95
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
$768K 0.21%
10,240
-1,116
-10% -$78.7K
MDYG icon
96
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.8B
$745K 0.2%
16,812
-1,299
-7% -$55.6K
UA icon
97
Under Armour Class C
UA
$2.77B
$735K 0.2%
29,200
-12,619
-30% -$349K
INDA icon
98
iShares MSCI India ETF
INDA
$6.89B
$720K 0.19%
26,843
-1,907
-7% -$53K
IEV icon
99
iShares Europe ETF
IEV
$1.67B
$708K 0.19%
18,253
-190
-1% -$7.25K
MINT icon
100
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$707K 0.19%
6,973
-4,713
-40% -$478K

Similar funds

Cabot Wealth Management's Q4 2016 Portfolio in Review

As of Q4 2016, Cabot Wealth Management held 160 positions worth $369M, down 5% from $389M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cabot Wealth Management withdrew a net $17.7M in Q4 2016, closing 15 positions and reducing 78 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $5.18M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Cabot Wealth Management opened a new position in State Street SPDR S&P Bank ETF worth $5.73M.

  • Cabot Wealth Management's largest Q4 2016 buy was State Street SPDR S&P Bank ETF: 131,882 shares worth $5.73M.
  • Cabot Wealth Management added most to Vanguard Extended Market ETF in Q4 2016, an estimated $2.38M increase.
  • Cabot Wealth Management's biggest Q4 2016 reduction was IQVIA, cutting an estimated $3.77M.
  • Cabot Wealth Management fully exited Ligand Pharmaceuticals in Q4 2016, selling an estimated $5.18M.
  • Cabot Wealth Management's ten largest holdings make up 26% of its $369M portfolio in Q4 2016.
  • Cabot Wealth Management opened 11 new positions and closed 15 in Q4 2016.
  • Cabot Wealth Management's portfolio value fell 5% quarter-over-quarter to $369M.

Based on Cabot Wealth Management's 13F filing for Q4 2016, filed 7 Feb 2017.